433 related articles for article (PubMed ID: 15937518)
1. Characterisation of cell-penetrating peptide-mediated peptide delivery.
Jones SW; Christison R; Bundell K; Voyce CJ; Brockbank SM; Newham P; Lindsay MA
Br J Pharmacol; 2005 Aug; 145(8):1093-102. PubMed ID: 15937518
[TBL] [Abstract][Full Text] [Related]
2. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
3. Study of uptake of cell penetrating peptides and their cargoes in permeabilized wheat immature embryos.
Chugh A; Eudes F
FEBS J; 2008 May; 275(10):2403-14. PubMed ID: 18397318
[TBL] [Abstract][Full Text] [Related]
4. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides.
Duchardt F; Fotin-Mleczek M; Schwarz H; Fischer R; Brock R
Traffic; 2007 Jul; 8(7):848-66. PubMed ID: 17587406
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of transportan 10 in PEI mediated plasmid delivery assay.
Kilk K; El-Andaloussi S; Järver P; Meikas A; Valkna A; Bartfai T; Kogerman P; Metsis M; Langel U
J Control Release; 2005 Mar; 103(2):511-23. PubMed ID: 15763630
[TBL] [Abstract][Full Text] [Related]
7. Cell transduction pathways of transportans.
Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
[TBL] [Abstract][Full Text] [Related]
8. Protein cargo delivery properties of cell-penetrating peptides. A comparative study.
Säälik P; Elmquist A; Hansen M; Padari K; Saar K; Viht K; Langel U; Pooga M
Bioconjug Chem; 2004; 15(6):1246-53. PubMed ID: 15546190
[TBL] [Abstract][Full Text] [Related]
9. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
[TBL] [Abstract][Full Text] [Related]
12. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
[TBL] [Abstract][Full Text] [Related]
13. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans.
Console S; Marty C; García-Echeverría C; Schwendener R; Ballmer-Hofer K
J Biol Chem; 2003 Sep; 278(37):35109-14. PubMed ID: 12837762
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides: tools for intracellular delivery of therapeutics.
Deshayes S; Morris MC; Divita G; Heitz F
Cell Mol Life Sci; 2005 Aug; 62(16):1839-49. PubMed ID: 15968462
[TBL] [Abstract][Full Text] [Related]
15. Cargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative study.
El-Andaloussi S; Järver P; Johansson HJ; Langel U
Biochem J; 2007 Oct; 407(2):285-92. PubMed ID: 17627607
[TBL] [Abstract][Full Text] [Related]
16. Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions.
Vives E
J Mol Recognit; 2003; 16(5):265-71. PubMed ID: 14523939
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo.
Mi Z; Mai J; Lu X; Robbins PD
Mol Ther; 2000 Oct; 2(4):339-47. PubMed ID: 11020349
[TBL] [Abstract][Full Text] [Related]
18. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
Fang B; Jiang L; Zhang M; Ren FZ
Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
[TBL] [Abstract][Full Text] [Related]
19. Delivery of 2-5A cargo into living cells using the Tat cell penetrating peptide: 2-5A-tat.
Zhou L; Thakur CS; Molinaro RJ; Paranjape JM; Hoppes R; Jeang KT; Silverman RH; Torrence PF
Bioorg Med Chem; 2006 Dec; 14(23):7862-74. PubMed ID: 16908165
[TBL] [Abstract][Full Text] [Related]
20. On the mechanisms of the internalization of S4(13)-PV cell-penetrating peptide.
Mano M; Teodósio C; Paiva A; Simões S; Pedroso de Lima MC
Biochem J; 2005 Sep; 390(Pt 2):603-12. PubMed ID: 15907190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
